SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its ...
Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...
Five former lobbyists have been appointed or nominated to President-elect Trump’s Cabinet, signaling he may not be as closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback